2024-2025 season
Seasonal vaccines preorder terms and conditions
Preorders may be modified until May 31, 2024. Starting June 1, 2024, preorders and orders will be considered firm and non-cancelable. Seasonal vaccines ship based on availability from the manufacturer and Cencora, or its entities, will not be held liable for product unavailability, shortages, or delays. Your preorder may be shipped to you in multiple shipments based on availability. All shipment notices sent during the 2024-2025 flu season will be sent by email. You are responsible for providing a regularly monitored email address. Account must be in good standing for order and shipment.
For Moderna COVID-19 vaccines: Please note there is a minimum order quantity of 4 units (40 doses) per item. Preorders that do not meet the minimum order quantity will not be processed. For questions, contact seasonalvaccines@amerisourcebergen.com.
Customer must provide appropriate licensure for sale and delivery before order can be shipped. All sales of seasonal vaccines are subject to the terms and conditions contained in the Customer Application. Standard fees apply. Prices are subject to change without notice. Please contact Customer Service if there are any questions. Any clinical or prescribing decisions are between you and the patient.
Returnability
Cencora, including the capabilities of AmerisourceBergen pharmaceutical distribution, accepts return requests for unused doses for credit at the end of the season based on manufacturers' terms and conditions. Please note that all return requests must comply with the terms listed in our seasonal vaccines return policy to qualify for return credit.
Flu vaccine products eligible for return include:
- Seqirus™: Up to 15% per presentation
- Sanofi Pasteur®: Up to 15% per presentation
- GlaxoSmithKline®: Up to 15% per presentation
- AstraZeneca: Up to 25% on FluMist®
COVID-19 vaccine products returnability: Cencora will accept return requests for a percentage of unused doses for credit based on manufacturers' terms and conditions.
COVID-19 vaccine products eligible for return include:
- Novavax: Up to 10%
- Moderna: Up to 10%
Terms and conditions are subject to change without notice.